Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Dec;4(Suppl 1):S94-8.
doi: 10.4103/0976-500X.120975.

Corticosteroid-related central nervous system side effects

Affiliations
Case Reports

Corticosteroid-related central nervous system side effects

Miriam Ciriaco et al. J Pharmacol Pharmacother. 2013 Dec.

Abstract

Corticosteroids have been used since the 50s as anti-inflammatory and immunosuppressive drugs for the treatment of several pathologies such as asthma, allergy, rheumatoid arthritis, and dermatological disorders. Corticosteroids have three principal mechanisms of action: 1) inhibit the synthesis of inflammatory proteins blocking NF-kB, 2) induce the expression of anti-inflammatory proteins by IkB and MAPK phosphatase I, and 3) inhibit 5-lipoxygenase and cyclooxygenase-2. The efficacy of glucocorticoids in alleviating inflammatory disorders results from the pleiotropic effects of the glucocorticoid receptors on multiple signaling pathways. However, they have adverse effects: Growth retardation in children, immunosuppression, hypertension, hyperglycemia, inhibition of wound repair, osteoporosis, metabolic disturbances, glaucoma, and cataracts. Less is known about psychiatric or side effects on central nervous system, as catatonia, decreased concentration, agitation, insomnia, and abnormal behaviors, which are also often underestimated in clinical practice. The aim of this review is to highlight the correlation between the administration of corticosteroids and CNS adverse effects, giving a useful guide for prescribers including a more careful assessment of risk factors and encourage the use of safer doses of this class of drugs.

Keywords: Adverse effects; central nervous system; corticosteroids; mood; psychosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Similar articles

Cited by

References

    1. Rhen T, Cidlowski JA. Antinflammatory action of glucocorticoids Antiinflammatory Action of Glucocorticoids — New mechanisms for old drugs. N Engl J Med. 2005;353:1711–23. - PubMed
    1. Rhen T, Cidlowski JA. Nuclear factor-kB and glucocorticoid receptors. In: Martini L, editor. Encyclopedia of endocrine diseases. Vol. 3. Boston: Elsevier Academic Press; 2004. pp. 391–8.
    1. The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972;13:694–8. - PubMed
    1. Wolkowitz OM. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 1994;19:233–55. - PubMed
    1. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21:55–89. - PubMed

Publication types